Immunohistochemical Expression of Vascular Endothelial Growth Factor and Microvessel Counting as Prognostic Indicators in Node-Negative Colorectal Cancer
- 1 January 2005
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 26 (1) , 1-8
- https://doi.org/10.1159/000084180
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cancer and Leukemia Group B 90206Clinical Cancer Research, 2004
- Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2003
- Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and TherapyJournal of Clinical Oncology, 2002
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal Of Cancer, 1996
- Tumor Angiogenesis as a Predictor of Recurrence and Survival in Patients with Node-Negative Colon CancerAnnals of Surgery, 1995
- 50. Standardizing the methodology of vessel density in breast cancer using immunohistochemistry and tumour microangiographyThe Breast, 1995
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995
- Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.The Journal of Experimental Medicine, 1991
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- QBEnd/10: A new immunostain for the routine diagnosis of Kaposi's sarcomaThe Journal of Pathology, 1990